| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |